Effect of Prophylactic Use of Intranasal Oil Formulations in the Hamster Model of COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection initiates with viral entry in the upper respiratory tract, leading to coronavirus disease 2019 (COVID-19). Severe COVID-19 is characterized by pulmonary pathologies associated with respiratory failure. Thus, therapeutics aimed at...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizvi, Zaigham Abbas, Tripathy, Manas Ranjan, Sharma, Nishant, Goswami, Sandeep, Srikanth, N, Sastry, J. L. N., Mani, Shailendra, Surjit, Milan, Awasthi, Amit, Dikshit, Madhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551705/
https://www.ncbi.nlm.nih.gov/pubmed/34721035
http://dx.doi.org/10.3389/fphar.2021.746729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551705/
https://www.ncbi.nlm.nih.gov/pubmed/34721035
http://dx.doi.org/10.3389/fphar.2021.746729

Ejemplares similares